245 related articles for article (PubMed ID: 8854197)
1. Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
Krause W; Schuhmann-Giampieri G; Bauer M; Press WR; Muschick P
Invest Radiol; 1996 Aug; 31(8):502-11. PubMed ID: 8854197
[TBL] [Abstract][Full Text] [Related]
2. Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Bollow M; Wolf KJ
Radiology; 1997 Nov; 205(2):361-6. PubMed ID: 9356615
[TBL] [Abstract][Full Text] [Related]
3. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits.
Krause W; Handreke K; Schuhmann-Giampieri G; Rupp K
Invest Radiol; 2002 May; 37(5):241-7. PubMed ID: 11979149
[TBL] [Abstract][Full Text] [Related]
5. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
6. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography with iodine-free contrast media.
Zwicker C; Hering M; Langer R
Eur Radiol; 1997; 7(7):1123-6. PubMed ID: 9265688
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
9. A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Wolf KJ
Radiology; 1997 Feb; 202(2):407-12. PubMed ID: 9015066
[TBL] [Abstract][Full Text] [Related]
10. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
Mühler A; Heinzelmann I; Weinmann HJ
Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans.
Schuhmann-Giampieri G; Mahler M; Röll G; Maibauer R; Schmitz S
J Clin Pharmacol; 1997 Jul; 37(7):587-96. PubMed ID: 9243351
[TBL] [Abstract][Full Text] [Related]
13. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
14. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
Schmitz SA; Mühler A; Wagner S; Wolf KJ
Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
[TBL] [Abstract][Full Text] [Related]
16. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Häberle JH; Balzer T; Shamsi K; Boese-Landgraf J; Wolf KJ
Radiology; 1997 Feb; 202(2):399-405. PubMed ID: 9015065
[TBL] [Abstract][Full Text] [Related]
17. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
[TBL] [Abstract][Full Text] [Related]
18. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
19. Contrast-to-noise ratios of different elements in digital mammography: evaluation of their potential as new contrast agents.
Diekmann F; Sommer A; Lawaczeck R; Diekmann S; Pietsch H; Speck U; Hamm B; Bick U
Invest Radiol; 2007 May; 42(5):319-25. PubMed ID: 17414528
[TBL] [Abstract][Full Text] [Related]
20. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.
Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S
Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
